Swiss Stem Cells Biotech
Swiss Stem Cells Biotech is a Swiss private biobank founded in 2005, offering cryopreservation of cord blood, adipose tissue, PBMCs, and DNA to consumers and healthcare partners, with FACT-NETCORD accreditation and a unique FOPH-approved hybrid banking model.
- Company typePrivate
- Founded2005
- HeadquartersVacallo, Switzerland
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Swiss Stem Cells Biotech does
Swiss Stem Cells Biotech (SSCB) is a Swiss private biobank founded in 2005 in Lugano, Switzerland, specializing in the cryopreservation of biological materials including umbilical cord blood and cord tissue (MyBabyCells), adipose-derived adult stem cells (AdultCells), peripheral blood mononuclear cells for induced pluripotent stem cell generation (EternaCell), and DNA. The company operates as one of the few private biobanks holding FACT-NETCORD accreditation and GMP certification in Switzerland, addressing individual consumers (expecting parents and adult patients), medical professionals, and third-party healthcare companies.
The business model combines one-time processing and collection fees with recurring annual storage subscriptions (with entry pricing from CHF 88), supplemented by DNA storage, contract manufacturing for Advanced Therapy Medicinal Products (ATMPs), and medical training through CELLS Academy. SSCB also operates a hybrid public-private banking model approved by the Swiss Federal Office of Public Health (FOPH) in 2020, partnering with the Women's Clinic of Inselspital in Bern and the Blood Transfusion Service of the Swiss Red Cross.
Distribution is achieved through partner hospitals nationwide and membership in international registries such as the World Marrow Donor Association (WMDA). The company operates with a small team of 1-10 employees from a Swiss headquarters, positioning itself as a "100% Swiss" provider in a trust-sensitive consumer category.
Swiss Stem Cells Biotech firmographics
Firmographics- Name
- Swiss Stem Cells Biotech
- Legal name
- Swiss Stem Cells Biotech
- Website
- https://sscb-stembiotech.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Swiss Stem Cells Biotech is a Swiss private biobank founded in 2005, offering cryopreservation of cord blood, adipose tissue, PBMCs, and DNA to consumers and healthcare partners, with FACT-NETCORD accreditation and a unique FOPH-approved hybrid banking model.
- Ownership category
- akta.pro rank
Swiss Stem Cells Biotech industry classification
Industry- Product category
- Stem Cell Biobank Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industry
- Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC)
Keywords
Where Swiss Stem Cells Biotech is headquartered
LocationHeadquarters
- HQ city
- Vacallo
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Swiss Stem Cells Biotech business model
Business model- GTM type
- B2C
- Offering type
- Services
Revenue model
- Stem Cell Cryopreservation Services: Recurring storage fees for cryopreservation of stem cells from umbilical cord blood, cord tissue, placental tissue, and adipose tissue. One-time processing fees combined with ongoing annual storage charges.
- DNA Storage Services: One-time or recurring fees for genetic code preservation services.
- Contract Manufacturing (ATMPs): Consultation, development, validation, approval, and production of tissue engineering and advanced biological products on behalf of third parties.
- CELLS Academy Training: Courses for medical professionals on regenerative medicine and minimally invasive surgery techniques.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Stem Cell Storage starting from CHF 88 |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Swiss Stem Cells Biotech product offering
Product offeringCore offering
Swiss Stem Cells Biotech is a Swiss-certified private biobank that processes and cryopreserves stem cells collected from umbilical cord blood, cord tissue, placental tissue, and adult adipose tissue. Samples are transported directly from partner hospital delivery rooms to its own GMP-certified, FACT-NETCORD accredited laboratory in Switzerland for processing and long-term storage, with a subscription-based storage model complemented by ancillary services such as DNA preservation, contract manufacturing of Advanced Therapy Medicinal Products (ATMPs), and professional training via CELLS Academy.
Product overview
Swiss Stem Cells Biotech operates as a Swiss-certified family biobank offering a portfolio of biological preservation services. The core offerings include MyBabyCells (umbilical cord blood and tissue banking) and AdultCells (adipose tissue stem cell banking for adult patients), supported by specialized services like EternaCell (peripheral blood mononuclear cell preservation) and DNA storage. The company offers contract manufacturing for ATMPs and advanced biological products. CELLS Academy provides educational courses for medical professionals. The Hybrid Banking Model represents a unique public-private partnership enabling family banking with optional anonymous donation to the global WMDA registry.
Differentiator
Problem solved
Functional benefit
Products and services
- MyBabyCells Stem cell banking service that collects, transports, processes, and cryopreserves stem cells from a newborn's umbilical cord blood and cord tissue for potential future family therapeutic use.
- AdultCells
- EternaCell
- Hybrid Banking Model Combined family protection and public donation model that allows cord blood samples to be entered into the World Marrow Donor Association (WMDA) global registry with explicit consent.
- DNA Storage
- Contract Manufacturing (ATMPs)
- CELLS Academy
Quantifiable outcome
- Applications in more than 80 established diseases
- +1 more outcomes
Companies that use Swiss Stem Cells Biotech
Customer profileSegments4 records
Ideal customer profiles4 records
Swiss Stem Cells Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Swiss Stem Cells Biotech partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Women's Clinic of Inselspital in BerncoreKey clinical partner in the Swiss public-private hybrid banking pilot project. Collaborates on the hybrid storage service available in clinics nationwide.
- Blood Transfusion Service of the Swiss Red Cross (SRC)coreStrategic partner in the hybrid banking model, collaborating on public donation aspects and global registry connectivity through WMDA.
- Swiss Stem Cells FoundationcoreCollaboration partner in CELLS Academy for medical professional education in regenerative medicine and minimally invasive surgery techniques.
- Partner Hospitals (nationwide clinics)minorPartner hospitals providing birth services where the hybrid banking model is available and where samples are collected directly from delivery rooms.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Swiss Stem Cells Biotech competitors and assessment
Company assessmentDirect peers
- Cryo-Cell International: US-listed cord blood and cord tissue banking company offering family storage of stem cells with similar B2C model targeting expecting parents. Comparable product offering (Umbilical Cord Blood + tissue preservation) and recurring storage revenue model.
- Cord Blood Registry (CBR): Largest US cord blood bank, now part of CooperCompanies, offering family cord blood and tissue banking with premium positioning. Comparable as the dominant scaled player in family cord blood banking.
- Cells4Life: UK-based cord blood and tissue bank offering family storage services across multiple cell types including cord blood, cord tissue, and placenta. Comparable UK/European B2C family biobank with similar service portfolio.
- Americord Registry: US-based cord blood and tissue bank offering family banking with multiple processing technology options. Comparable US family cord blood bank with similar B2C positioning and service tiers.
- Esperite (The Cell Factory): European stem cell biobank and cell therapy services company offering family cord blood banking and cell expansion services. Comparable as a European cord blood bank with broader cell therapy ambitions.
- ViaCord: US-based cord blood bank offering family cord blood and cord tissue storage with recurring storage fees. Directly comparable business model and target customer (expectant parents) with established brand recognition.
- FamiCord: Europe's largest cord blood bank operating across multiple countries with PBMSC, cord tissue, and regenerative medicine services. Directly comparable to SSCB as a multi-service family stem cell bank with similar B2C model and European footprint.
- Smart Cells International: UK-based stem cell bank focused on umbilical cord blood and tissue storage with international shipping capabilities. Comparable as a European-focused family stem cell storage provider.
Others
- TrakCel: Cell therapy supply chain management and orchestration software provider serving cell therapy developers and biobanks. Adjacent ecosystem player supporting the same cord blood and cell therapy value chain that SSCB operates in.
Broad incumbents
- BioLife Solutions: US-listed supplier of cryopreservation media, storage products, and cold chain solutions for the cell and gene therapy industry. Comparable as an adjacent/ecosystem player in the cryopreservation value chain serving similar biobank and cell therapy customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Swiss Stem Cells Biotech social profiles
Digital presenceSwiss Stem Cells Biotech compliance and trust
Trust signalCompliance2 records
Swiss Stem Cells Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Swiss Stem Cells Biotech leadership team
Management profileNumber of profiles
Swiss Stem Cells Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Swiss Stem Cells Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Swiss Stem Cells Biotech
What does Swiss Stem Cells Biotech do?
Swiss Stem Cells Biotech is a Swiss-certified private biobank that processes and cryopreserves stem cells collected from umbilical cord blood, cord tissue, placental tissue, and adult adipose tissue. Samples are transported directly from partner hospital delivery rooms to its own GMP-certified, FACT-NETCORD accredited laboratory in Switzerland for processing and long-term storage, with a subscription-based storage model complemented by ancillary services such as DNA preservation, contract manufacturing of Advanced Therapy Medicinal Products (ATMPs), and professional training via CELLS Academy.
Is Swiss Stem Cells Biotech a public or private company?
Swiss Stem Cells Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Swiss Stem Cells Biotech founded?
Swiss Stem Cells Biotech was founded in 2005. It employs 1 to 10 people.
Where is Swiss Stem Cells Biotech based?
Swiss Stem Cells Biotech is headquartered in Vacallo, Switzerland, in the Europe region.
How does Swiss Stem Cells Biotech make money?
Four revenue lines are on record. Stem Cell Cryopreservation Services are the primary driver. The others are DNA Storage Services, contract Manufacturing (ATMPs) and CELLS Academy Training.
Who are Swiss Stem Cells Biotech's main competitors?
Direct peers on record are Cryo-Cell International, Cord Blood Registry (CBR), Cells4Life, Americord Registry, Esperite (The Cell Factory), ViaCord, FamiCord and Smart Cells International. TrakCel is listed as an others. BioLife Solutions is listed as a broad incumbent.
Does Swiss Stem Cells Biotech have an API?
No public API is recorded for Swiss Stem Cells Biotech.
What industry is Swiss Stem Cells Biotech in?
Swiss Stem Cells Biotech's product category is Stem Cell Biobank Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAAKAC, Cell Therapy Manufacturing Services (GMP, autologous/allogeneic). Its NAICS code is 621991 and its SIC code is 2836.